Russian billionaire Tinkov agrees to pay $500 million over U.S. tax charges
- Wall St ends up with Goldman; Dow posts biggest weekly rise since June
- Goldman Sachs (GS) Smashes Analyst 3Q Views on Robust M&A and Underwriting Activity
- Tesla (TSLA) Stock: Jefferies Raises Price Target on Higher Capacity Ramp and Sustained Demand, Berlin Giga Will Set New Design and Assembly Standards Says Analyst
- Food, fuels lift U.S. import prices in September
- SEC to Allow First Ever Bitcoin (BTC) ETF - Report
FILE PHOTO: Oleg Tinkov, Chairman of the Board of Directors of Tinkoff Bank, attends a session of the St. Petersburg International Economic Forum (SPIEF), Russia June 7, 2019. REUTERS/Maxim Shemetov/File Photo
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
MOSCOW (Reuters) -Billionaire Oleg Tinkov, whose online bank is Russia's second biggest credit card issuer, pleaded guilty on Friday to filing a false U.S. tax return and agreed to pay $507 million in taxes, interest and penalties, the U.S. Department of Justice said.
He had been accused of concealing $1 billion in assets and income when renouncing his U.S. citizenship in 2013.
Tinkov, whose businesses including Tinkoff Bank are held by his investment company TCS Group, was arrested in London in February 2020 in connection with the indictment, and released on bail as he was fighting acute leukaemia.
"Mr Tinkov is grateful for the opportunity to resolve this case in a humanitarian way and is hopeful that it will allow him to focus his energy on fighting his illness," his lawyers said in a statement.
His sentencing hearing is scheduled for Oct. 29, which is expected to wrap up the case.
A spokesperson for Tinkov said the businessman has enough funds to cover the fines without selling his assets, including shares in TCS.
(Reporting by Anton Kolodyazhnyy and Tatiana VoronovaWriting by Vladimir SoldatkinEditing by Peter Graff)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump-backed challengers to Republican lawmakers lag in fundraising
- U.S. FDA declines to approve Revance's frown-line treatment
- Boeing workers stage protest near Seattle over U.S. vaccine mandate
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!